FGL2 and cancer: Fgl2-expressing CD8+ T cells were contained almost entirely (p < 0.001, Fig. 1b) within the population of cells that express PD-1, a cell surface receptor that marks antigen-experienced and functionally exhausted CD8+ T cells in the context of cancer and chronic viral infection.